Exclusive elemental diet impacts on the gastrointestinal microbiota and improves symptoms in patients with chronic pouchitis

Journal of Crohn's and Colitis

Volumn 7, Issue 6, 2013, Pages 460-466

  McLaughlin, S D ^a,b,c   Culkin, A ^a   Cole, J ^c   Clark, S K ^a   Tekkis, P P ^b   Ciclitira, P J ^c   Nicholls, R J ^a,b   Whelan, K ^c  

^a ST MARK S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Elemental diet; Ileo anal pouch; Inflammatory bowel disease; IPAA; Pouchitis; Restorative proctocolectomy; Ulcerative colitis

Indexed keywords

CIPROFLOXACIN; METRONIDAZOLE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHRONIC POUCHITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; ELEMENTAL DIET; FECES ANALYSIS; FECES CULTURE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; ILEITIS; INTESTINE FLORA; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT DURATION;

ADULT; CHRONIC DISEASE; CLOSTRIDIUM; ENDOSCOPY, GASTROINTESTINAL; EUBACTERIUM; FECES; FEMALE; FOOD, FORMULATED; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; OLIGONUCLEOTIDE PROBES; POUCHITIS; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 84877016375     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.07.009     Document Type: Article

References (45)

1. McLaughlin S.D., Clark S.K., Tekkis P.P., Ciclitira P.J., Nicholls R.J. Aliment Pharmacol Ther 2008 May, 27(10):895-909. Epub 2008 Feb 9. Review. PMID: 18266993.
2. McLaughlin S.D., Clark S.K., Bell A.J., Tekkis P.P., Ciclitira P.J., Nicholls R.J. An open study of antibiotics for the treatment of pre-pouch ileitis following restorative proctocolectomy with ileal pouch-anal anastomosis. Aliment Pharmacol Ther 2009 Jan, 29(1):69-74. Epub 2008 Oct 3. 10.1111/j.1365-2036.2008.03858.x.
3. McLaughlin S.D., Clark S.K., Tekkis P.P., Ciclitira P.J., Nicholls R.J. An open study of maintenance antibiotic therapy for chronic antibiotic-dependent pouchitis: efficacy, complications and outcome. Colorectal Dis 2011 Apr, 13(4):438-444. PMID: 20041929. 10.1111/j.1463-1318.2009.02166.x.
4. Mimura T., Rizzello F., Helwig U., Poggioli G., Schreiber S., Talbot I.C., Nicholls R.J., Gionchetti P., Campieri M., Kamm M.A. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004, 53(1):108-114.
5. Sambuelli A., Boerr L., Negreira S., Gil A., Camartino G., Huernos S., et al. Budesonide enema in pouchitis--a double-blind, double-dummy, controlled trial. Aliment Pharmacol Ther 2002 Jan, 16(1):27-34.
6. Pardi D.S., Sandborn W.J. Systematic review: the management of pouchitis. Aliment Pharmacol Ther 2006, 23(8):1087-1096.
7. Calabrese C., Gionchetti P., Rizzello F., Liguori G., Gabusi V., Tambasco R., et al. Short-term treatment with infliximab in chronic refractory pouchitis and ileitis. Aliment Pharmacol Ther 2008, 27(9):759-764.
8. Ferrante M., D'Haens G., Dewit O., Baert F., Holvoet J., Geboes K., et al. Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: A Belgian case series. Inflamm Bowel Dis 2010 Feb, 16(2):243-249.
9. Tulchinsky H., Hawley P.R., Nicholls J. Long-term failure after restorative proctocolectomy for ulcerative colitis. Ann Surg 2003, 238(2):229-234.
10. Zachos M., Tondeur M., Griffiths A.M. Enteral nutritional therapy for inducing remission of Crohn's disease. Cochrane Database Syst Rev 2001, (3):CD000542.
11. Menezes J.S., Andrade M.C., Senra B., Rodrigues V.S., Vaz N.M., Faria A.M. Immunological activities are modulated by enteral administration of an elemental diet in mice. Clin. Nutr. 2006, 25(4):643-652.
12. Teahon K., Smethurst P., Pearson M., Levi A.J., Bjarnason I. The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease. Gastroenterology 1991, 101(1):84-89.
13. Fell J.M., Paintin M., Arnaud-Battandier F., Beattie R.M., Hollis A., Kitching P., et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther 2000, 14(3):281-289.
14. Sanderson I.R., Boulton P., Menzies I., Walker-Smith J.A. Improvement of abnormal lactulose/rhamnose permeability in active Crohn's disease of the small bowel by an elemental diet. Gut 1987, 28(9):1073-1076.
15. Pimentel M., Constantino T., Kong Y., Bajwa M., Rezaei A., Park S. A 14-day elemental diet is highly effective in normalizing the lactulose breath test. Dig. Dis. Sci. 2004, 49(1):73-77.
16. Hartman C., Eliakim R., Shamir R. Nutritional status and nutritional therapy in inflammatory bowel diseases. World J Gastroenterol 2009, 15(21):2570-2578.
17. Kajiura T., Takeda T., Sakata S., Sakamoto M., Hashimoto M., Suzuki H., et al. Change of intestinal microbiota with elemental diet and its impact on therapeutic effects in a murine model of chronic colitis. Dig Dis Sci 2009, 54(9):1892-1900.
18. Sandborn W.J., Tremaine W.J., Batts K.P., Pemberton J.H., Phillips S.F. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin. Proc. 1994, 69(5):409-415.
19. Mimura T., Rizzello F., Helwig U., Poggioli G., Schreiber S., Talbot I.C., et al. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment. Pharmacol. Ther. 2002, 16(5):909-917.
20. Shen B., Brzezinski A., Fazio V.W., Remzi F.H., Achkar J.P., Bennett A.E., et al. Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice. Aliment. Pharmacol. Ther. 2005, 22(8):721-728.
21. Coffey J.C., Winter D.C., Neary P., Murphy A., Redmond H.P., Kirwan W.O. Quality of life after ileal pouch-anal anastomosis: an evaluation of diet and other factors using the Cleveland Global Quality of Life instrument. Dis Colon Rectum 2002, 45(1):30-38.
22. McLaughlin S.D., Clark S.K., Shafi S., Petrovksa L., Tekkis P.P., Ciclitira P.J., et al. Fecal coliform testing to identify effective antibiotic therapies for patients with antibiotic-resistant pouchitis. Clin. Gastroenterol. Hepatol. 2009, 7(5):545-548.
23. Riordan A.M., Hunter J.O., Cowan R.E., Crampton J.R., Davidson A.R., Dickinson R.J., et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet 1993, 342(8880):1131-1134.
24. Gorard D.A., Hunt J.B., Payne-James J.J., Palmer K.R., Rees R.G., Clark M.L., et al. Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. Gut 1993, 34(9):1198-1202.
25. Malchow H., Steinhardt H.J., Lorenz-Meyer H., et al. Feasibility and effectiveness of a defined-formula diet regimen in treating active Crohn's disease. European Cooperative Crohn's Disease Study III. Scand J Gastroenterol 1990, 25(3):235-244.
26. Madden M.V., McIntyre A.S., Nicholls R.J. Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 1994, 39(6):1193-1196.
27. Falk A., Olsson C., Ahrne S., Molin G., Adawi D., Jeppsson B. Ileal pelvic pouch microbiota from two former ulcerative colitis patients, analysed by DNA-based methods, were unstable over time and showed the presence of Clostridium perfringens. Scand J Gastroenterol 2007, 42(8):973-985.
28. McLaughlin S.D., Walker A.W., Churcher C., et al. The bacteriology of pouchitis: a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencing. Ann Surg 2010, 252(1):90-98.
29. McLaughlin S.D., Clark S.K., Tekkis P.P., Nicholls R.J., Ciclitira P.J. The bacterial pathogenesis and treatment of pouchitis. Therap. Adv. Gastroenterol. 2010, 3(6):335-348.
30. Cotter P.D. Small intestine and microbiota. Curr Opin Gastroenterol 2011, 27(2):99-105.
31. Zella G.C., Hait E.J., Glavan T., Gevers D., Ward D.V., Kitts C.L., et al. Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis. Inflamm. Bowel. Dis. 2011, 17(5):1092-1100.
32. Scarpa M., Grillo A., Pozza A., Faggian D., Ruffolo C., Scarpa M., et al. TLR2 and TLR4 up-regulation and colonization of the ileal mucosa by Clostridiaceae spp. in chronic/relapsing pouchitis. J Surg Res. 2011, 169(2):e145-e154.
33. Booijink C.C., Zoetendal E.G., Kleerebezem M., De Vos W.M. Microbial communities in the human small intestine: coupling diversity to metagenomics. Future Microbiol 2007, 2(3):285-295.
34. Franks A.H., Harmsen H.J., Raangs G.C., Jansen G.J., Schut F., Welling G.W. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 1998, 64(9):3336-3345.
35. Louis P., Young P., Holtrop G., Flint H.J. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ Microbiol 2010, 12(2):304-314.
36. Cavaglieri C.R., Nishiyama A., Fernandes L.C., Curi R., Miles E.A., Calder P.C. Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes. Life Sci 2003, 73(13):1683-1690.
37. Louis P., Flint H.J. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 2009, 294(1):1-8.
38. Hamer H.M., Jonkers D., Venema K., Vanhoutvin S., Troost F.J., Brummer R.J. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 2008, 27(2):104-119.
39. Whelan K., Judd P.A., Preedy V.R., Simmering R., Jann A., Taylor M.A. Fructooligosaccharides and fiber partially prevent the alterations in fecal microbiota and short-chain fatty acid concentrations caused by standard enteral formula in healthy humans. J Nutr. 2005, 135(8):1896-1902.
40. Benus R.F., van der Werf T.S., Welling G.W., Judd P.A., Taylor M.A., Harmsen H.J., et al. Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects. Br J Nutr 2010, 104(5):693-700.
41. Hopkins M.J., Macfarlane G.T. Nondigestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro. Appl Environ Microbiol 2003, 69(4):1920-1927.
42. Henderson L., Gregory J., Irving K., Swan G. The National Diet and Nutrition Survey: adults aged 19-64 years, volume 2 Energy, protein, carbohydrate, fat and alcohol intake 2003, The Stationery Office, London.
43. Croagh C., Shepherd S.J., Berryman M., Muir J.G., Gibson P.R. Pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colon. Inflamm Bowel Dis 2007, 13(12):1522-1528.
44. Mahowald M.A., Rey F.E., Seedorf H., Turnbaugh P.J., Fulton R.S., Wollam A., et al. Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc Natl Acad Sci USA 2009, 106(14):5859-5864.
45. Maddox P.H., Jenkins D. J Clin Pathol 1987 Oct, 40(10):1256-1257. No abstract available. PMID: 3316291.